Suzetrigine Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the clinical use of suzetrigine during breastfeeding. Because suzetrigine is more than 99% bound to plasma proteins and its active metabolite is more than 96% protein bound, the amounts in milk are likely to be low. If the mother requires suzetrigine, it is not a reason to discontinue breastfeeding. However, until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
